RBC Capital Markets
-
Catalent Pharma and Thomas Cook — a reverse Yankee issuer and a UK holidays operator — on Thursday released guidance for high yield deals amounting some €900m in a market that has been mute since November 15. -
-
A pair of public sector borrowers hit screens this week for dollar syndications, providing an unexpectedly strong climax to 2016.
-
National Australia Bank on Wednesday issued its second dollar benchmark of the year and managed to fund it at a tighter level than it could have hoped for in euros. However, the more conspicuous funding advantage for borrowers lies in sterling covered bonds.
-
Royal Bank of Canada’s capital markets division dragged on the bank’s fourth quarter results, posting a 13% year on year decline in profits.
-
National Australia Bank issued its second dollar benchmark of the year and managed to fund at a slightly tighter level than it could have hoped for in euros. However, the more conspicuous funding advantage is in sterling covered bonds
-
Rentenbank sold what is likely to be its final benchmark of the year on Tuesday.
-
Rentenbank has announced that it will sell a five year dollar bond on Tuesday, winding up its 2016 funding programme and making the most of what a banker at one of the leads called “one of the last good windows of the year”.
-
Zimmer Biomet, the US orthopaedic reconstructive products producer, has mandated three banks to arrange its debut in the euro bond market, which may be a dual tranche transaction.
-
BHP Billiton’s partnership with the IFC for the world’s first ‘forests’ bond has inspired others to look at similar projects.
-
GDS Holdings received a thumping response from investors for its $192.5m Nasdaq IPO, but priced it below the initial range to capture long-only demand and a higher-quality book.
-
Chinese data firm GDS Holdings has opened its potential $270.2m US IPO, which is expected to replicate the strong interest received by other recent listings in the country from Mainland names.
